Nonsteroidal antiandrogen which has been shown to be effective in the treatment of prostate cancer. Also induces cell death by a pathway that is independent of changes in mitochondrial membrane potential and Bcl-2 action.
Product Literature References
Antiandrogen-induced cell death in LNCaP human prostate cancer cells
: E.C. Lee, et al.; Cell Death Differ. 10
, 761 (2003), Abstract
Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours
: A. Maucher & E. von Angerer; J. Cancer Res. Clin. Oncol. 119
, 669 (1993), Abstract